摘要
目的探讨在开展心肾阳虚型慢性心衰治疗工作期间,观察真武汤加减治疗方法的应用价值。方法选择我院2015年5月—2017年9月收治的70例心肾阳虚型慢性心衰患者作为实验对象;由数字奇偶法对所有心肾阳虚型慢性心衰患者分组;对照组(35例)选择依那普利+呋塞米+地高辛片药物施治;观察组(35例)选择真武汤加减方法施治;最终就2组心肾阳虚型慢性心衰患者的心功能疗效、射血分数、中医证候疗效与N端脑利钠肽水平展开对比。结果同对照组心肾阳虚型慢性心衰患者心功能疗效、射血分数、中医证候疗效与N端脑利钠肽水平展开对比,观察组心肾阳虚型慢性心衰患者获得显著改善(P<0.05)。结论合理应用真武汤加减方法施治,显著能够改善患者心功能疗效、射血分数、中医证候疗效与N端脑利钠肽水平,从而优化心肾阳虚型慢性心衰患者的预后能力以及生活能力。
Objective To explore the application value of modified Zhenwu decoction on chronic heart failure of heart and kidney yang deficiency. Methods A total of 70 patients with chronic heart failure (CHD) were enrolled in our hospital from May 2015 to September 2017. Patients with chronic heart failure were randomly divided into control group (35 eases) used enalapril, furosemide and digoxin tablets during clinical heart and kidney yang deficiency in the treatment of chronic heart failure during treatment and observation group (35 cases) applied Zhenwu decoction during clinical development of heart and kidney yang type of chronic heart failure treatment. The cardiac function, ejection fraction, TCM syndrome and N-terminal brain natriuretic peptide levels between the two groups was compared. Results Comparing with the control group, the curative effect of cardiac function, ejection fraction, TCM syndromes and N-terminal brain natriuretic peptide in the observation group were significantly improved ( P 〈 0.05 ). Conclusion The clinical application of Zhenwu decoction can significantly promote cardiac function, ejection fraction, TCM syndrome and N-terminal brain natriuretic peptide, and thus optimize the prognosis and living ability.
出处
《光明中医》
2018年第4期511-513,共3页
GUANGMING JOURNAL OF CHINESE MEDICINE
关键词
真武汤加减
心肾阳虚型慢性心衰
中医药疗法
Zhenwu decoction
Chronic heart failure of heart and kidney yang deficiency
Clinical effect
Therapy of TCM